Peritoneal Surface Malignancies | Retroperitoneal Sarcoma | CRS+HIPEC
Operate at the highest level. Teach globally. Impact patients beyond the OR.
Clinical Expertise
Comprehensive management of peritoneal carcinomatosis from colorectal, ovarian, gastric, and appendiceal origins using CRS+HIPEC. 15 years of experience. National reference centre (CSUR).
Expert compartmental resection of retroperitoneal soft tissue sarcomas including WDLPS, DDLPS, and LMS. Complex multivisceral procedures.
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. 50–60 procedures per year at a high-volume centre.
Recurrent pelvic tumours, sacral chordoma, pelvic reconstruction. Multidisciplinary approach.
For patients
Peritoneal carcinomatosis, sarcoma, HIPEC, palliative surgery, recovery, and FAQs — explained in plain language.
My own project
A platform for preparing surgical certification exams: a bank of more than 10,000 questions, every answer explained and referenced to a guideline, an oral exam simulator that questions you back, and a study plan matched to the specific board you are sitting.
I write it myself, as a practising surgical oncologist — not a content agency. Every question comes out of practice and is referenced to NCCN, ESMO, ESSO, PSOGI or JGCA, so what is learned is the reasoning, not the key.
50-question free trial · no credit card · no auto-renewal
Surgical oncology, HPB, coloproctology, endocrine, breast, oesophagogastric, bariatric and transplant.
The book
Surgical Oncology Board Review
A board review manual for surgical oncology: exam pearls, the trials that changed practice, TNM staging and questions with commented answers, in a single volume.
It was not born in an office but at Memorial Sloan Kettering Cancer Center, operating on retroperitoneal sarcoma and peritoneal malignant disease, and was finished at Hospital Gregorio Marañón.
Authors
Pablo Lozano Lominchar, MD, PhD, EBPSM
Luis González Bayón, MD, PhD
With Juan Carbonell, MD
Available for Kindle. The paperback edition is coming soon.
International collaboration
Peritoneal carcinomatosis is uncommon in any single centre. No hospital accrues enough cases on its own to answer the questions that matter, which is why this work is done as a network.
In July 2026, took part in Beijing in the programme behind the creation of the International Research Center for Peritoneal Surface Oncology (IRCPSO) at Tsinghua University, alongside teams from China, Japan, the Netherlands, Spain and India.
Training & affiliations
Personalised care from an internationally trained surgical oncologist.